Winson Cai on Muck Rack

Winson Cai

As seen in: Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Winson

Contact Winson, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

|
By Yusuke Isshiki, Xi Chen, Matt Teater, Ioannis Karagiannidis, Winson Cai, Cem Meydan, Min Xia, Hao Shen, Johana Gutierrez, Vigneshwari Easwar Kumar, Sebastian Carrasco, Madhu M. Ouseph, Samuel Yamshon, Peter Martin, Ofir Griess, Efrat Shema, Patrizia Porazzi, Marco Ruella, Renier J Brentjens, Giorgio G. Inghirami, Roberta Zappasodi, Amy Chadburn, Ari M Melnick, Wendy Béguelin
| Cell Press Verified
Keywords EZH2 T cell immunotherapy CAR-T bispecific antibodies follicular lymphoma DLBCL Get full text access Log in, subscribe or purchase for full access. References 1. Schuster, S.J. ∙ Svoboda, J. ∙ Chong, E.A. ... Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas N. Engl. J. Med. 2017; 377:2545-2554 2. Locke, F.L. ∙ Miklos, D.B. ∙ Jacobson, C.A. ... Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma N. Engl. J. Med. 2022; 386:640-654 3. Bishop, M.R. ∙ Dickinson, M.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified